Jaguar End Period Cash Flow vs Capital Expenditures Analysis
JAGX Stock | USD 1.04 0.05 5.05% |
Jaguar Animal financial indicator trend analysis is infinitely more than just investigating Jaguar Animal Health recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jaguar Animal Health is a good investment. Please check the relationship between Jaguar Animal End Period Cash Flow and its Capital Expenditures accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jaguar Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
End Period Cash Flow vs Capital Expenditures
End Period Cash Flow vs Capital Expenditures Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Jaguar Animal Health End Period Cash Flow account and Capital Expenditures. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Jaguar Animal's End Period Cash Flow and Capital Expenditures is -0.01. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Jaguar Animal Health, assuming nothing else is changed. The correlation between historical values of Jaguar Animal's End Period Cash Flow and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Jaguar Animal Health are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of End Period Cash Flow i.e., Jaguar Animal's End Period Cash Flow and Capital Expenditures go up and down completely randomly.
Correlation Coefficient | -0.01 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
End Period Cash Flow
Capital Expenditures
Capital Expenditures are funds used by Jaguar Animal Health to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Jaguar Animal operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most indicators from Jaguar Animal's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jaguar Animal Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jaguar Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. Selling General Administrative is likely to drop to about 12.5 M in 2024. Issuance Of Capital Stock is likely to drop to about 21.8 M in 2024
Jaguar Animal fundamental ratios Correlations
Click cells to compare fundamentals
Jaguar Animal Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Jaguar Animal fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 36.4M | 42.8M | 53.3M | 47.5M | 50.8M | 31.9M | |
Other Current Liab | 3.5K | 4.5M | 6.4M | 7.1M | 3.8M | 2.7M | |
Total Current Liabilities | 15.4M | 13.2M | 15.5M | 30.3M | 14.0M | 13.4M | |
Total Stockholder Equity | 10.7M | 17.2M | 11.6M | (657K) | 5.0M | 6.2M | |
Net Tangible Assets | (17.3M) | (7.2M) | (7.1M) | (11.0M) | (9.9M) | (10.4M) | |
Retained Earnings | (133.1M) | (166.9M) | (219.5M) | (266.9M) | (308.2M) | (292.8M) | |
Accounts Payable | 5.4M | 4.8M | 4.9M | 5.8M | 5.0M | 4.0M | |
Cash | 3.5M | 8.1M | 17.1M | 5.5M | 6.5M | 5.1M | |
Other Assets | 154.0K | 37K | 446K | 1.0 | 1.15 | 1.09 | |
Net Receivables | 1.7M | 4.6M | 2.1M | 2.5M | 2.0M | 1.6M | |
Other Current Assets | 553.0K | 2.4M | 4.3M | 7.4M | 10.3M | 10.9M | |
Other Stockholder Equity | 142.0M | 184.1M | 231.1M | 267.0M | 313.9M | 329.5M | |
Total Liab | 25.7M | 25.6M | 41.4M | 48.8M | 45.9M | 25.1M | |
Short Long Term Debt | 6.8M | 3.8M | 3.2M | 15.9M | 18.3M | 19.2M | |
Total Current Assets | 9.5M | 17.8M | 28.4M | 22.3M | 28.0M | 29.4M | |
Short Term Debt | 7.1M | 3.8M | 3.7M | 16.8M | 5.2M | 5.9M | |
Intangible Assets | 26.0M | 24.3M | 22.7M | 22.4M | 20.1M | 20.0M | |
Common Stock | 5.5K | 11K | 5K | 7K | 8.1K | 5.3K | |
Property Plant Equipment | 760.6K | 710.2K | 677K | 1.7M | 2.0M | 1.0M | |
Short Long Term Debt Total | 7.6M | 16.2M | 29.4M | 34.8M | 37.1M | 38.9M | |
Net Debt | 4.1M | 8.1M | 12.3M | 29.4M | 30.6M | 32.2M | |
Cash And Short Term Investments | 3.5M | 8.1M | 17.1M | 5.5M | 6.5M | 5.5M | |
Common Stock Total Equity | 10.5K | 6.5K | 5.5K | 11K | 12.7K | 13.3K | |
Liabilities And Stockholders Equity | 36.4M | 42.8M | 53.3M | 47.5M | 50.8M | 33.7M | |
Non Current Liabilities Total | 10.3M | 12.4M | 25.9M | 18.5M | 31.9M | 33.5M | |
Property Plant And Equipment Net | 710.2K | 677K | 1.7M | 1.7M | 1.7M | 1.2M | |
Current Deferred Revenue | 4.9M | 2.9M | 4.5M | 7.1M | 8.2M | 8.6M | |
Non Current Assets Total | 26.9M | 25.1M | 24.8M | 25.1M | 22.8M | 22.4M | |
Common Stock Shares Outstanding | 22.1K | 171.7K | 596.2K | 1.3M | 384.5K | 273.8K | |
Inventory | 2.1M | 2.8M | 4.9M | 7.0M | 9.2M | 9.6M | |
Property Plant And Equipment Gross | 710.2K | 677K | 2.0M | 2.1M | 2.4M | 1.2M | |
Non Currrent Assets Other | 154.0K | 37K | 446K | 995K | 1.0M | 961.4K | |
Retained Earnings Total Equity | (62.4M) | (94.6M) | (133.1M) | (166.9M) | (150.2M) | (142.7M) | |
Capital Surpluse | 79.7M | 99.9M | 142.0M | 184.1M | 211.7M | 222.3M | |
Accumulated Other Comprehensive Income | (9.0T) | (224.1K) | (42.8M) | (680K) | (652.0K) | (684.6K) | |
Net Invested Capital | 16.2M | 33.4M | 39.8M | 33.0M | 37.9M | 32.5M | |
Net Working Capital | (5.9M) | 4.6M | 13.0M | (8.0M) | (9.2M) | (9.7M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Jaguar Stock Analysis
When running Jaguar Animal's price analysis, check to measure Jaguar Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jaguar Animal is operating at the current time. Most of Jaguar Animal's value examination focuses on studying past and present price action to predict the probability of Jaguar Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jaguar Animal's price. Additionally, you may evaluate how the addition of Jaguar Animal to your portfolios can decrease your overall portfolio volatility.